Purchase Order 75N93019P00708
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,670.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the STEADYLITE PLUS 1000ML KIT. The contract, which does not have a set-aside designation, was awarded on August 1, 2019 with a completion date of August 23, 2019. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides medical imaging products and services to...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Revvity Health Sciences, Inc. for a Steadylite Plus Reporter Gene Assay Reagent System. The $23,209.50 contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that has provided a variety of medical devices and equipment, including automation systems for genetic...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Revvity Health Sciences, Inc. for seven units of STEADYLITE PLUS 1000ML KIT (catalog 6066759) on July 11, 2017, with a ceiling value of $22,751.80 at $3,242.40 per unit. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure with ultimate completion scheduled for August 18, 2017. No small business set-aside applies to this commercial supply purchase.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $23,891.30 on December 31, 2019, for seven units of STEADYLITE PLUS equipment with firm fixed-price pricing. Place of performance is Shelton, Connecticut. The order was set for ultimate completion by December 30, 2020. No small business set-aside was used. Revvity Health Sciences is a large business manufacturer and service provider...
- This is a $139,310.40 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The contract is for the delivery of 6066769 BRITELITE PLUS 100 ML KIT medical imaging products. It does not have a small business set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging and laboratory...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. for $5,308.00 in onsite support services. The contract has a period of performance through August 1, 2015. No set-aside was used for this award. Revvity Health Sciences, Inc. is a for-profit medical imaging company that provides laboratory equipment, maintenance services, and...
- This federal contract award to Revvity Health Sciences, Inc. is for the supply of a REVVITY INC MICROBETA2 PLATE READER WITH 6-DETECTORS AND ACCESSORIES to the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award was made on August 29, 2024 with a ceiling value of $133,115.10 and an ultimate completion date of February 14, 2025. The contract is a firm fixed-price purchase order and does not utilize any...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price purchase order contract to Revvity Health Sciences, Inc. for $5,472.00. The contract is for the provision of medical imaging products and services, with a period of performance from September 15, 2017 to September 17, 2018. This contract was not set aside for any small business category. Revvity Health Sciences, Inc. is a for-profit...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. The $209,734.00 contract is for the delivery of AMBIS # 1933336 BRITELITE PLUS 1000ML KIT, catalog # 6066769. The award was made on December 4, 2018, and the ultimate completion date is October 31, 2021. This contract does not have a set-aside designation. Revvity...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Revvity Health Sciences, Inc. to provide STEADYLITE PLUS KITS. The award, valued at $23,891.30, does not have a set-aside designation and was completed on June 24, 2020. Revvity Health Sciences, Inc. is a for-profit organization and manufacturer of goods that has previously received federal prime contracts and subcontracts to supply laboratory equipment and services, such as automated plate readers, imaging cytometers, and mass spectrometers, to agencies including the NIH, Centers for Disease Control and Prevention, Department of Defense, and Department of Veterans Affairs. The parent company, Revvity Inc., has also supported federal agencies through its Medical Imaging division, delivering items like liquid chromatography systems and automation applications for genetic research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 6/25/19 |